Joint Meeting of the Nonprescription Drugs Advisory Committee and the Advisory Committee for Reproductive Health Drugs; Notice of Meeting

Summary

The FDA will hold a joint meeting of the Nonprescription Drugs Advisory Committee and the Advisory Committee for Reproductive Health Drugs to discuss various topics, including the review of new drug applications and the evaluation of safety and efficacy data. The meeting is scheduled to take place on March 15, 2023, at the FDA White Oak Campus in Silver Spring, Maryland.